retatrutide dosing frequency clinical trial Guide: 1-12 mg Weekly Triple Agonist (2026) retatrutide clinical trial dosing frequency

When to contact your GP: Persistent or severe nausea/vomiting preventing adequate fluid intake Severe, persistent abdominal pain which could indicate pancreatitis New or worsening depression, anxiety, or suicidal thoughts Severe headaches or visual disturbances Unexplained cognitive changes or confusion Signs of hypoglycaemia (if taking alongside insulin or sulfonylureas) NICE guidance recommends regular monitoring during GLP-1 receptor agonist therapy

Immune Defense : Saliva contains enzymes and antibodies that help control bacterial growth and prevent infections like oral thrush

compounding landscape

Endocrinology 162:bqab185

You know that feeling when your skin feels tight and dry after washing